- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Restoration of type I interferon signaling in intrahepatically primed CD8+ T cells promotes functional differentiation
Keigo Kawashima 1 , Masanori Isogawa 2 , Masaya Onishi 3 , Ian Baudi 1 , Satoru Saito 4 , Atsushi Nakajima 4 , Takashi Fujita 5 , Yasuhito Tanaka 6
Affiliations
Affiliations
1
Department of Virology & Liver unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
2
Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
3
Department of Virology & Liver unit, Nagoya City University Graduate School of Medical Science, Nagoya, Japan.
4
Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Japan.
5
Institute for Frontier Life and Medical Science, Kyoto University, Kyoto, Japan.
6
Department of Gastroenterology and Hepatology, Kumamoto University, Kumamoto, Japan.
PMID: 33400688 DOI: 10.1172/jci.insight.145761
Abstract
Hepatitis B virus (HBV)-specific CD8+ T cells fail to acquire effector functions after priming in the liver, but the molecular basis for the dysfunctionality is poorly understood. By comparing the gene expression profile of intrahepatically primed, dysfunctional HBV-specific CD8+ T cells with that of systemically primed, functional effector counterparts, we found that the expression of interferon-stimulated genes (ISGs) is selectively suppressed in the dysfunctional CD8+ T cells. The ISG suppression was associated with impaired phosphorylation of STAT1 in response to IFNα treatment. Importantly, a strong induction of type interferons (IFN-Is) in the liver facilitated the functional differentiation of intrahepatically primed HBV-specific CD8+ T cells in association with the restoration of ISGs expression in the T cells. These results suggest that intrahepatic priming suppresses IFN-I signaling in CD8+ T cells, which may contribute to the dysfunctionality. The data also suggest a therapeutic value of the robust induction of intrahepatic IFN-Is for the treatment of chronic HBV infection.
Keywords: Cellular immune response; Hepatitis; Immunology; Infectious disease; T cells.
|
|